Background
The American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology (ASCO) collaborated to develop a clinical practice guideline on the use of molecular marker testing for patients with early and advanced colorectal cancer. This evidence‐based clinical practice guideline will help establish standard molecular marker testing, guide targeted therapy decisions, and advance personalized care for these patients.
Objectives.—To develop evidence-based guideline recommendations through a systematic review of the litera- ture to establish standard molecular biomarker testing of colorectal cancer (CRC) tissues to guide epidermal growth factor receptor (EGFR) therapies and conventional chemotherapy regimens.
Descarregar a guideline aqui
